Biomarker testing is shaping the future of colorectal cancer care

Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...

Colorectal cancer is now the deadliest cancer for those under 50, in grim milestone

Colorectal cancer has since jumped up from being the fifth-leading cancer death in the early 1990s.

Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication in npj ...
Talk Business & Politics

UAMS receives $3.5 million from CDC for colorectal cancer screening

The Centers for Disease Control and Prevention (CDC) awarded more than $3.5 million to the University of Arkansas for Medical Sciences (UAMS) to lead a five-year statewide effort to ...